Compare Mutual Funds

Pros
3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
6/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 8 Months

13 Years 8 Months

Fund AUM

₹1217 Cr

₹8636 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.21%

0.79%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

44

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(8.87%)
  2. Divi's Laboratories Ltd(4.87%)
  3. Ajanta Pharma Ltd(4.7%)
  4. Gland Pharma Ltd(3.98%)
  5. Lupin Ltd(3.8%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

1

1

Top 3 Sectors

Health

(100%)

Health

(100%)

Equity %

94.45%

97.92%

Debt %

-

-

P/E

38.11

36.71

P/B

5.35

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

8.37%

6.46%

3-Month Return

22.25%

16.52%

6-Month Return

15.38%

10.62%

1-Year Return

15.33%

9.5%

3-Year Return

27.52%

22.56%

5-Year Return

15.61%

13.75%

Sharpe

1.16

0.97

Alpha

2.15

-0.78

Beta

0.96

0.89

Standard Deviation

16.35

15.23

Information Ratio

0.57

-0.76

Description

UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Kamal Gada

Sailesh Raj Bhan, Amber Singhania, Kinjal Desai

Most Popular Comparisons